Geneva-based Transmutex secures 20million in extension series A round funding. Union Square Ventures and Steel Atlas led the round, and At One Ventures (USA), HCVC (France/USA), and AlleyCorp (USA) were among the new and returning investors who participated.
Read also – Canada-based Cnergreen Secures $2Million in Seed Funding
with the involvement of private investors, FONGIT (Switzerland), House Of Ventures (USA), Presight Capital (USA), Verve Ventures (Switzerland), and Tiny Supercomputer Investment Co. (UK).
The money will be used by the business to advance the development of its offering.
Transmutex, which was established on July 29, 2019, is developing non-self-sustaining reaction technology by connecting a particle accelerator with a subcritical fuel assembly.
Read also – Arizona-based MY DR NOW Secures $60Million in Funding
About Transmutex
Transmutex is an innovative firm whose goal is to completely rethink nuclear energy. Their creative solution tackles the main issues of nuclear reactor proliferation, safety, and cost.
Read also – NYC-based GreenSpark Secures $9.4Million in Funding
